Delays in Accessing Innovative Drugs for Patients in Cyprus
May 9, 2025
Cyprus ranks 22nd among 36 European countries in patient access to innovative drugs. The time from drug approval to patient availability is 531 days. MPs are concerned about delays in the approval of treatment requests from cancer patients, highlighting the seriousness of the issue for human lives. Immediate action is needed from the Health Insurance Organization.